The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Deep learning-based predictive biomarker for immune checkpoint inhibitor response in metastatic non-small cell lung cancer.
 
Sehhoon Park
No Relationships to Disclose
 
Chang Ho Ahn
Employment - Lunit
 
Geunyoung Jung
Employment - Lunit; Samsung Bioepis
 
Sarah Lee
Employment - Lunit
 
Kyunghyun Paeng
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit
 
Jiwon Shin
Employment - Lunit
 
Inwan Yoo
Employment - Lunit
 
Hyun Ae Jung
No Relationships to Disclose
 
Jong-Mu Sun
No Relationships to Disclose
 
Jin Seok Ahn
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb-Ono Pharmaceutical; Eisai; Janssen; Menarini; MSD; Pfizer; Roche
Consulting or Advisory Role - Samsung Bioepis
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; MSD
 
Keunchil Park
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Hanmi; Kyowa Hakko Kirin; Lilly; MSD; Novartis; Ono Pharmaceutical; Roche
Speakers' Bureau - AZD; Boehringer Ingelheim
Research Funding - AstraZeneca
 
Yoon La Choi
No Relationships to Disclose
 
Sang-Yong Song
No Relationships to Disclose
 
Se-Hoon Lee
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Novartis
Research Funding - Merck
Travel, Accommodations, Expenses - Novartis